Silvia Noonan
Senior Medical Affairs Expert
Silvia is a Regulatory Affairs consultant with over a decade of experience guiding clinical development programs in the pharmaceutical and biotech industries.
She brings expertise in supporting start-ups and small to mid-sized enterprises in clinical trial applications, orphan drug designations, scientific advice procedures, and pediatric investigation plans. Silvia has held key roles at both CROs and pharma companies, including RLM Consulting, Napo Therapeutics, Dompé Farmaceutici, JSB Solutions, and Pharma D&S, consistently delivering strategic, high-impact regulatory solutions.
Through extensive interactions with Health Authorities and hands-on experience preparing regulatory dossiers, she developed the strategic mindset to support pharmaceutical companies in defining regulatory goals for investigational products (from phase 1 to phase 3 trials).
Silvia holds a degree in Chemistry and Pharmaceutical Technology and a Master’s in Clinical Research from the University of Milan. She has contributed to peer-reviewed publications, conducted preclinical research at the U.S. National Institutes of Health (NIH), and served as a lecturer in Regulatory Affairs.